Siemens Mobility Austria GmbH Chooses the TrioMed Active Antimicrobial Mask to Protect Its Employees
MIRABEL, Quebec, Canada, Oct. 20, 2020 (GLOBE NEWSWIRE) -- i3 BioMedical Inc. is pleased to announce that its TrioMed Active Antimicrobial mask has been chosen by Siemens Mobility Austria GmbH.
Siemens Mobility Austria GmbH did evaluate multiple options to protect its employees and selected the TrioMed Active Mask type IIR after a careful review of the different products available on the market. The scientifically proven efficacy of the TrioMed Active Mask that deactivates within minutes over 99% of the Coronavirus pathogens that could be present on the mask’s external surface was a crucial selection parameter.
“We are pleased to add Siemens Mobility Austria GmbH to the list of corporations that now use our TrioMed mask technology to provide an enhanced level ofactiveprotection to their employees,” says Pierre Jean Messier, i3 BioMedical’s CEO. “In a market that is literally flooded by all kind of masks and mask-like products from newly improvised manufacturers making claims about the ability of their products to protect against the COVID-19, it is understandable that selecting the right mask is difficult. Being the manufacturer of the TrioMed Active mask and a recognized long-standing medical device manufacturer, it is an honor to be selected by one of the world’s leading company, to protect their team members.”
Protective Masks - Mask with Active Ingredient
A medical protective mask from Canada offers protection against viruses (and bacteria) of all kinds: Triomed Iodine Technology is the name of the only mask with an active ingredient. Iodine, one of the oldest disinfectants, is integrated into the mask structure - is completely odorless, skin-friendly and hypoallergenic.
This not only protects the others, but also the mask wearer. According to the manufacturer and university report (from Toronto University in Canada and one of the leading US American test laboratories, Nelson Labs in Salt Lake City in the US state of Utah), every virus and bacterium that hits the mask is "destroyed" within a few minutes.
This technology was developed 12 years ago by that company, which developed the masks during the Ebola epidemic, brought it onto the market in response against possible SARS viruses epidemics and patented it.
Since Ebola and SARS played a subordinate role in Europe, the mask also remained largely unknown. However, some large Austrian companies are already using this active protection for their employees.